Related Experiment Video
Updated: May 25, 2026
12:23
Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
Comparative proteomic profiling of mammalian cell lysates using phosphopeptide microarrays
Liqian Gao1, Mahesh Uttamchandani, Shao Q Yao
1Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543.
Chemical Communications (Cambridge, England)
|January 19, 2012
Summary
Researchers identified cancer biomarkers by analyzing human phosphotyrosine-containing peptides. This peptide library approach revealed specific binding profiles in cell lysates, aiding biomarker discovery for cancer states.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Phosphotyrosine-based signaling is crucial in cellular processes.
- Dysregulated phosphotyrosine signaling is implicated in various cancers.
- Identifying specific phosphotyrosine-protein interactions is key for biomarker development.
Purpose of the Study:
- To create a comprehensive map of phosphotyrosine peptide binding in cell lysates.
- To identify novel biomarkers associated with different cancer states.
- To leverage microarray technology for high-throughput screening of protein interactions.
Main Methods:
- Utilized a library of 176 human phosphotyrosine-containing peptides.
- Employed a two-colour microarray format for binding assays.
- Performed pull-down assays to isolate and identify interacting proteins.
- Analyzed binding profiles to determine specificity and identify potential biomarkers.
Main Results:
- Established distinct cell lysate binding profiles for the peptide library.
- Identified several candidate biomarkers through pull-down and identification methods.
- Demonstrated the utility of the microarray approach for biomarker discovery in cancer.
Conclusions:
- The study successfully identified potential biomarkers for cancer states using a phosphotyrosine peptide microarray.
- This method provides a valuable tool for dissecting phosphotyrosine signaling networks.
- Further validation of identified biomarkers is warranted for clinical application.
